JESSICA SCHILKE: Open Payments
NPI 1942047618 · MYSTIC, CT. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$570 in 14 payments from 11 companies in 2025. Trend: 2023 $0 · 2024 $310 · 2025 $570
Food & beverage: $570
| Company | Payments | Amount |
|---|---|---|
| Abbott Laboratories | 2 | $164 |
| Actelion Pharmaceuticals US, Inc. | 1 | $127 |
| Alnylam Pharmaceuticals Inc. | 2 | $50 |
| Merck Sharp & Dohme LLC | 2 | $42 |
| Baxter Healthcare | 1 | $38 |
| Amgen Inc. | 1 | $28 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $27 |
| Novo Nordisk Inc | 1 | $27 |
| PFIZER INC. | 1 | $24 |
| Novartis Pharmaceuticals Corporation | 1 | $22 |
Products named: CARDIOMEMS, UPTRAVI, ONPATTRO, VERQUVO, Hillrom - Carnation Ambulatory Monitor, REPATHA, JARDIANCE, Ozempic.
Industry payments across CT — which companies pay providers there.
